OTLC 8-K 2026-06-29

Oncotelic Therapeutics, Inc. (OTLC) 8-K dated 2026-06-29 — accession 0001493152-26-031124. This URL is the filing, not the OTLC hub.

Oncotelic Therapeutics, Inc. (OTLC) is a biotechnology company listed on OTCQB.

Oncotelic Therapeutics, Inc. filed a 8-K on 2026-06-29. Accession 0001493152-26-031124.

Cached items: 1.01, 2.03, 3.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported OTLC revenue for 2026-06-30 was $250.0K. Net income was -$1.8M. OTLC currently screens at market cap $17.8M and trailing P/E 0.1.

Not investment advice. The OTLC SEC hub lists recent forms. The stock page is the research view.